Ultragenyx Pharmaceutical Inc. RARE
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and ultra-rare genetic diseases. Ultragenyx Pharmaceutical Inc. currently markets medicines for conditions such as X-linked hypophosphatemia, mucopolysaccharidosis VII, and certain metabolic disord…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees1,294
TickerRARE
Statistics
Market Cap$2.72B
Revenue (TTM)$673.0M
Net Income-$575.0M
Net Margin-85.4%
EPS$-6.10
P/E-4.11
P/S3.38
P/B-10.53
EV/EBITDA-6.14
ROE787.7%
Dividend Yield—
Price$27.71
Data: Twelve Data · Revenue = mcap / P/S